Pembrolizumab for the Treatment of Recurrent High Grade Neuroendocrine Carcinoma
Clinical trial NCT03190213 · TERMINATED
Trial details
- NCT number
- NCT03190213
- Sponsor
- University of Utah
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-04
- Primary completion
- 2018-12-13
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.